Barium swallow was consistent with recurrent Zenker's diverticulum and patient presents now for surgical management.
Past Medical History: PMH:  HTN, DM2, ^chol, OA/DJD, angioedema  PSH:  Deviated septum repair and tonsillectomy, Zenker Diverticulum s/p cricomyotomy and diverticulopexy ([**8-12**])  [**Last Name (un) 1724**]: ASA 81 QOD, Amlodipine - dose uncertain, HCTZ 25', Lovastatin 40', Qvar 80mcg 2INH [**Hospital1 **], ICaps MV, fish oil, Caltrate 600(1500)-400, Centrum silver MVI   Social History: Occupation: retired Drugs: none Tobacco: 1ppd for 60 years Alcohol: 1glass [**Doctor First Name **] or wine/night, no prev withdrawal Other: Lives in senior community, retired, daughter [**Name (NI) **] [**Telephone/Fax (1) 63926**] next of [**Doctor First Name **]   Family History: No h/o DM.
No other contrib fam hx   Physical Exam: Discharge P/E: VS: T: 98.8  P: 93  BP: 140/88  RR: 18  O2sat: 95% 2L GEN: WD, WN in NAD HEENT: NCAT, EOMI, anicteric CV: RRR, +S1S2 w no M/R/G PULM: CTA B/L w no W/R/R, normal excursion, no respiratory distress BACK: no vertebral tenderness, no CVAT ABD: soft, NT, ND, no mass, no hernia PELVIS: deferred EXT: WWP, no CCE, no tenderness, 2+ B radial/DP/PT NEURO: A&Ox3, no focal neurologic deficits DERM: no rashes/lesions/ulcers   Pertinent Results: LABORATORIES:  MICROBIOLOGY: Bronchial washing [**7-26**]: 4000/ml commensural respiratory flora  PATHOLOGY: Pending  [**2122-7-31**] 07:40AM BLOOD WBC-8.8 RBC-4.81 Hgb-14.9 Hct-43.7 MCV-91 MCH-30.9 MCHC-34.1 RDW-14.2 Plt Ct-280 [**2122-7-31**] 07:40AM BLOOD Glucose-125* UreaN-13 Creat-0.5 Na-139 K-3.5 Cl-99 HCO3-28 AnGap-16  ESOPHAGEAL STUDY [**7-30**] No evidence of obstruction or perforation.
Following extubation POD5 pt noted to have L facial droop.
Upon arrival, bronchoscopy was performed which showed significant angioedema.
The patient was stable from a pulmonary standpoint; vital signs were routinely monitored.
Given facial droop POD5, S&S decided to perform video swallow study POD6 which showed.
Swallowing: Esophageal barium study was perform, no evidence of obstruction or perforation.
A swallowing study was repeated on [**8-3**], it showed penetration of thin and nectar thick liquids during the swallow as well as backflow of liquids and purees from the esophagus into the airway after the swallow, Full liquid diet was recommended.
Medications on Admission: [**Last Name (un) 1724**]: ASA 81 QOD, Amlodipine - dose uncertain, HCTZ 25', Lovastatin 40', Qvar 80mcg 2INH [**Hospital1 **], ICaps MV, fish oil, Caltrate 600(1500)-400, Centrum silver MVI, metformin 1000mg [**Hospital1 **]   Discharge Medications: 1. bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Angioedema 3.
